Content about Drugs

Kroger announced Thursday it will acquire the outstanding shares of Axium Pharmacy Holdings, a leading specialty pharmacy, and merge the two companies. By now, it should be clear that specialty is becoming an increasingly important part of the retail pharmacy mix, having grown more than sixfold in revenues between 2000 and 2011, with everyone from Rite Aid to Costco to Hy-Vee biting off a piece for themselves.

WOONSOCKET, R.I. — As part of its continuing efforts to help communities affected by Hurricane Sandy, CVS/pharmacy has announced that it is waiving prescription co-payments, deductibles and other financial liability related to prescription medications for patients who cannot pay at selected stores in the hardest hit neighborhoods in New York City and surrounding communities. 

Over-the-counter medications continue to gain in popularity among consumers, who — whether as a matter of cost savings or convenience — are increasingly turning to OTCs to treat their conditions, including both acute, episodic conditions like the common cold and such chronic conditions as frequent pain and allergy. 


To see more Patient Views, click here.

Earlier this week, DSN reported that members of a prescription drug program offered by Humana to Medicare beneficiaries will soon be able to obtain 10 generic hypertension drugs from Walmart for a penny.

It's certainly good news for people with high blood pressure, but it also has big implications for the pharmacy retail industry.

PARSIPPANY, N.J. — Watson Pharmaceuticals on Wednesday announced the sale of its Rugby over-the-counter business to the Harvard Drug Group — a distributor and provider of private-label OTCs and generic prescription products under the Major Pharmaceuticals brand — for approximately $117 million.  

"I am confident that Major, with its leadership position as a marketer of OTC products, will be more strategically positioned to maximize the value of the long-known and respected Rugby name," stated Paul Bisaro, president and CEO of Watson.

SUPPLIER NEWS — Summit Laboratories recently launched a pair of skin care items ideal for people with diabetes. Aside from kidney and eye disorders, skin disorders are one of the top challenges for diabetics. Summit Laboratories’ Dr. Fred Summit Type 1 & 2 Diabetic Rehydrating Cleanser and Cream provide a one-two punch to help promote proper leg and foot care. The pair of products are being merchandised as a solution for dry and itching skin associated with diabetes, and retail for $6.99 and 
$12.99, respectively.


SILVER SPRING, Md. — The Food and Drug Administration has launched a campaign designed to educate consumers about online rogue pharmacies, the agency said Friday.

The FDA announced the launch of BeSafeRx, which includes resources for patients and caregivers who might purchase medications online.

 WASHINGTON — The Senate on Wednesday passed a resolution naming October as National Medicine Abuse Awareness Month. The resolution was sponsored by Sens. Diane Feinstein, D.-Calif., and Chuck Grassley, R-Iowa, and urges communities to carry out programs and activities to educate parents and youth of the potential dangers associated with medicine abuse.

WOONSOCKET, R.I. — CVS Caremark announced that it has joined with a group of public and private sector partners and will sponsor the "The Medicine Abuse Project," a multiyear effort by The Partnership at Drugfree.org to raise awareness and curb the abuse of prescription drugs and over-the-counter medicines. The project's goal is to prevent half a million teens from abusing medicines over the next five years.

PARSIPPANY, N.J. — Walgreens will offer products and other resources for women who have fertility complications due to cancer treatment, under a partnership with Ferring Pharmaceuticals announced Thursday.

DENVER — While the growth in healthcare costs remains a threat in the United States, the growth in drug expenditures is moderating, but numerous opportunities exist for retail, according to a speech delivered Tuesday morning at the National Association of Chain Drug Stores' 2012 Pharmacy and Technology Conference in Denver by Doug Long, VP industry relations of healthcare industry research firm IMS Health.

INDIANAPOLIS — A biotech drug made by Eli Lilly for osteoporosis appeared no more or less effective than a pharmaceutical drug available as a generic in treating women with related bone fractures, but was more effective in some other measures, according to results of a late-stage clinical trial released Tuesday.